ATE393162T1 - Transkriptionsfaktor-e2f-dna-bindungsdomäne hemmende peptide und ihre verwendung - Google Patents
Transkriptionsfaktor-e2f-dna-bindungsdomäne hemmende peptide und ihre verwendungInfo
- Publication number
- ATE393162T1 ATE393162T1 AT00901225T AT00901225T ATE393162T1 AT E393162 T1 ATE393162 T1 AT E393162T1 AT 00901225 T AT00901225 T AT 00901225T AT 00901225 T AT00901225 T AT 00901225T AT E393162 T1 ATE393162 T1 AT E393162T1
- Authority
- AT
- Austria
- Prior art keywords
- seq
- binding domain
- transcription factor
- dna binding
- inhibitory peptides
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 108010093502 E2F Transcription Factors Proteins 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 230000006369 cell cycle progression Effects 0.000 abstract 2
- 230000004568 DNA-binding Effects 0.000 abstract 1
- 102000001388 E2F Transcription Factors Human genes 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9901710.5A GB9901710D0 (en) | 1999-01-26 | 1999-01-26 | Peptide inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE393162T1 true ATE393162T1 (de) | 2008-05-15 |
Family
ID=10846537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00901225T ATE393162T1 (de) | 1999-01-26 | 2000-01-26 | Transkriptionsfaktor-e2f-dna-bindungsdomäne hemmende peptide und ihre verwendung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6841385B2 (de) |
| EP (1) | EP1144437B1 (de) |
| AT (1) | ATE393162T1 (de) |
| AU (1) | AU2118500A (de) |
| CA (1) | CA2359043A1 (de) |
| DE (1) | DE60038667D1 (de) |
| GB (1) | GB9901710D0 (de) |
| WO (1) | WO2000044771A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201220901D0 (en) | 2012-11-21 | 2013-01-02 | Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh | CD44v6-derived peptides for treating pancreatic cancer |
| GB201220891D0 (en) | 2012-11-21 | 2013-01-02 | Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh | CD44v6-derived peptides for treating breast cancers |
| GB201421647D0 (en) | 2014-12-05 | 2015-01-21 | Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie | CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5728802A (en) * | 1992-05-06 | 1998-03-17 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1) |
| JP3329868B2 (ja) * | 1992-09-30 | 2002-09-30 | 株式会社クラレ | ペプチドおよびこれを担体上に固定化してなる吸着剤 |
| WO1994018345A1 (en) * | 1993-02-05 | 1994-08-18 | Affymax Technologies N.V. | Receptor-binding antiproliferative peptides |
| WO1998014474A1 (en) * | 1996-09-30 | 1998-04-09 | Kyowa Hakko Kogyo Co., Ltd. | E2f activity inhibitory compounds |
| GB9626589D0 (en) * | 1996-12-20 | 1997-02-05 | Prolifix Ltd | Peptides |
| EP1060249A1 (de) * | 1998-03-02 | 2000-12-20 | The Government of the United States represented by the Secretary of the Department of Health and Human Services | Epitope peptiden, die immunogenes gegen streptococcus pneumoniae sind |
-
1999
- 1999-01-26 GB GBGB9901710.5A patent/GB9901710D0/en not_active Ceased
-
2000
- 2000-01-26 EP EP00901225A patent/EP1144437B1/de not_active Expired - Lifetime
- 2000-01-26 WO PCT/GB2000/000227 patent/WO2000044771A1/en not_active Ceased
- 2000-01-26 CA CA002359043A patent/CA2359043A1/en not_active Abandoned
- 2000-01-26 DE DE60038667T patent/DE60038667D1/de not_active Expired - Lifetime
- 2000-01-26 AU AU21185/00A patent/AU2118500A/en not_active Abandoned
- 2000-01-26 AT AT00901225T patent/ATE393162T1/de not_active IP Right Cessation
-
2001
- 2001-07-26 US US09/912,414 patent/US6841385B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20030013169A1 (en) | 2003-01-16 |
| AU2118500A (en) | 2000-08-18 |
| EP1144437A1 (de) | 2001-10-17 |
| CA2359043A1 (en) | 2000-08-03 |
| GB9901710D0 (en) | 1999-03-17 |
| DE60038667D1 (de) | 2008-06-05 |
| WO2000044771A1 (en) | 2000-08-03 |
| US6841385B2 (en) | 2005-01-11 |
| EP1144437B1 (de) | 2008-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2261249A3 (de) | KDR-Peptide und Impfstoffe damit | |
| DE69820885D1 (de) | Peptidsequenzen als scharnierregionen in proteinen wie immunglobulinfragmenten und ihre verwendung in der heilkunde | |
| DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
| DK0912176T3 (da) | Anvendelse af pyridylalkan-, pyridylalken- og/eller pyridylalkynsyreamider til behandling af tumorer eller immunosuppression | |
| NO20040222L (no) | Peptider til fjerning eller destruksjon av celler | |
| DK1185648T3 (da) | Fremgangsmåder og sammensætninger til inhibition af neoplastisk cellevækst | |
| MX2009000656A (es) | Acidos nucleicos que se fijan a sdf-i. | |
| DK1007537T3 (da) | Receptor-protein med betegnelsen 2F1 | |
| ATE299029T1 (de) | Verfahren und zusammensetzungen zur peptidsynthese (t-20) | |
| IL165007A0 (en) | Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis | |
| IL159966A0 (en) | Nucleic acids, polypeptides, and methods for modulating apoptosis | |
| DE69426121D1 (de) | Gen grb3-3, variante und ihre verwendungen | |
| IL157464A0 (en) | Zinc finger binding domains for nucleotide sequence ann | |
| DK1234025T3 (da) | Humane enzymer fra metalloproteasefamilien | |
| ATE393162T1 (de) | Transkriptionsfaktor-e2f-dna-bindungsdomäne hemmende peptide und ihre verwendung | |
| WO2001093897A3 (en) | Angiostatin and endostatin binding proteins and methods of use | |
| DE60042793D1 (de) | Inhibitor des hepatozytwachstumsfaktoraktivators und dessen verwendung zur modulation von angiogenese und herzvaskularisierung | |
| SG146640A1 (en) | Isolated photoprotein mtclytin, and use thereof | |
| ATE240349T1 (de) | Peptide zur inhibierung von hpv e6-proteinen | |
| WO2007013358A3 (en) | Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent | |
| ATE395935T1 (de) | An der oberfläche von karzinomzellen lokalisiertes colligin/hsp47 | |
| WO2004011483A3 (en) | Isolated, ssx-2 and ssx-2 related peptides useful as hla binders and ctl epitopes, and uses thereof | |
| WO2007066018A3 (fr) | Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques | |
| ATE235509T1 (de) | Peptide zur inhibition von hpv e7 proteinen | |
| WO2004013167A3 (en) | Purified polypeptides from enterococcus faecalis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |